首页> 美国卫生研究院文献>The Journal of Neurology and Psychopathology >Normal activation of the supplementary motor area in patients with Parkinsons disease undergoing long-term treatment with levodopa.
【2h】

Normal activation of the supplementary motor area in patients with Parkinsons disease undergoing long-term treatment with levodopa.

机译:接受左旋多巴长期治疗的帕金森氏病患者补充运动区的正常激活。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Regional cerebral blood flow (rCBF) changes in cortical motor areas were measured during a movement of the dominant right hand in 15 patients with Parkinson's disease deprived of their usual levodopa treatment, in 11 patients with Parkinson's disease undergoing long-term treatment with levodopa, and in 15 normal volunteers. The supplementary motor areas were significantly activated in the normal subjects and in the patients receiving levodopa but not in the patients deprived of levodopa. The contralateral primary sensory motor area was significantly activated in all three groups. The ipsilateral primary sensory motor cortex was not activated in the normal subjects and the non-treated patients but was in the patients treated with levodopa. It is concluded that the supplementary motor area hypoactivation which is observed in akinetic non-treated patients with Parkinson's disease is not present in patients undergoing long-term treatment with levodopa. This result suggests that (a) levodopa improves the functional activity of supplementary motor areas in Parkinson's disease and (b) there is no pharmacological tolerance to this effect. The ipsilateral primary motor cortex activation observed in the patients treated with levodopa could be related to levodopa-induced abnormal involuntary movements.
机译:在15名没有常规左旋多巴治疗的帕金森氏病患者,11名接受左旋多巴长期治疗的帕金森氏病患者中,在优势右手运动期间测量了皮质运动区域的局部脑血流量(rCBF)变化。在15名正常志愿者中。在正常受试者和接受左旋多巴的患者中,辅助运动区明显激活,但在缺乏左旋多巴的患者中未激活。在所有三组中,对侧主要感觉运动区均被明显激活。在正常受试者和未治疗的患者中,同侧原发感觉运动皮层未激活,但在左旋多巴治疗的患者中被激活。结论是,在长期未接受左旋多巴治疗的患者中,在没有进行运动能力治疗的帕金森氏病患者中观察到的补充运动区功能减退。该结果表明(a)左旋多巴改善了帕金森氏病中补充运动区的功能活性,并且(b)对该作用没有药理学耐受性。在左旋多巴治疗的患者中观察到的同侧原发性运动皮层激活可能与左旋多巴引起的异常不自主运动有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号